EXISTING PARTNERSHIPS Therabel Pharma Belgium has signed several strategic and commercial alliances. A number of licence and joint marketing agreements have been signed with international pharmaceutical groups, such as Bayer, MSD, Helsinn, etc. Therabel Pharma also has agreements with certain academic and university centres concerning Research and Development, particularly relating to new pharmaceutical forms.     Licence agreements and co-marketing - MSD (USA) : Loortan  (Losartan) - BAYER (Germany) : Proflox  (Moxifloxacine) - HELSINN HEALTHCARE (Switzerland) : Mesulid  (Nimesulide) - IBSA (Switzerland) : Flector Tissugel   (Diclofenac Epolamine)   Licence and joint marketing agreements - Pharma Deal :   medical professions - Patch Pharma : pharmacists   Ferrer-Therabel Joint-Venture A joint-venture was signed between Laboratoires FERRER and THERABEL PHARMA which initially concerned the marketing of Remodulin in the Benelux.

DEVELOPMENT OBJECTIVES   Therabel Pharma is continuing to pursue its strategy for finding new partners in order to obtain new licences or new joint marketing agreements for innovative products, both in niche markets and in larger market segments.           Contact the Business Development Manager